J&J | Capitaux Propres Et Réserves



Equity Capital And Reserves Changement Date
AbbVie USD 1.46B 1.86B 2025-03
Abbott USD 50.83B 1.76B 2025-06
Amgen USD 7.43B 1.22B 2025-06
AstraZeneca USD 44.72B 3.68B 2025-06
Baxter International USD 7.05B 90M 2025-03
Bayer EUR 30.5B 2.08B 2025-06
Becton, Dickinson and Co. USD 25.47B 231M 2025-06
Biogen USD 17.63B 655.3M 2025-06
Boston Scientific USD 22.21B 443M 2025-03
Bristol-Myers Squibb USD 17.49B 100M 2025-06
CONMED USD 1B 25.23M 2025-06
Cooper Companies USD 8.29B 160.6M 2025-04
Dexcom USD 2.57B 306.5M 2025-06
Edwards Lifesciences USD 10.19B 193.2M 2025-03
Eli Lilly USD 18.27B 2.43B 2025-06
Gilead Sciences USD 19.67B 596M 2025-06
GlaxoSmithKline GBP 14.35B 197M 2025-06
Globus Medical USD 4.3B 207.61M 2025-06
Hologic USD 4.84B 223.8M 2025-06
Insulet USD 1.46B 132.2M 2025-06
Integra LifeSciences USD 1.04B 485.48M 2025-06
Intuitive Surgical USD 17.95B 745.4M 2025-06
J&J USD 78.11B 6.62B 2025-03
Medtronic USD 48.02B 1.36B 2025-04
Merck USD 49.06B 725M 2025-06
Merit Medical Systems USD 1.49B 59.62M 2025-06
Novartis USD 42.05B 3.6B 2025-06
Pfizer USD 88.7B 1.64B 2025-06
Regeneron Pharmaceuticals USD 29.94B 551.3M 2025-06
Roche Holding CHF 36.16B 3.28B 2024-12
Sanofi 70.28B 3.8B 2025-06
Stryker USD 21.19B 261M 2025-06
Tandem Diabetes Care USD 133.28M 22.01M 2025-06
Teva Pharmaceutical Industries USD 6.83B 572M 2025-06
Vertex Pharmaceuticals USD 17.18B 679.1M 2025-06
Zimmer Biomet Holdings USD 12.53B 130.5M 2025-06
Zoetis USD 4.98B 322M 2025-06


J&J Capitaux Propres Et Réserves - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.